Global Herceptin market size is expected to reach $9.92 by 2030 at 5.8%, increasing incidence of breast cancer fueling the growth of the market due to rising patient cases and demand for targeted therapies
Read More
Global Herbal Shampoo market size is expected to reach $8.83 by 2030 at 7.5%, surge in e-commerce driving the growth of the market due to increasing accessibility and consumer convenience
Read More
Global HER2-Positive Breast Cancer market size is expected to reach $15.23 billion by 2030 at 6.8%, impact of immunotherapy adoption on the her2-positive breast cancer market
Read More
Global HER2-Negative Breast Cancer market size is expected to reach $25.41 billion by 2030 at 7.6%, rising breast cancer incidence drives growth of the market
Read More
Hepatorenal Syndrome Sector Forecast Shows Robust Momentum, Climbing to $1.91 Billion With 6.9% CAGR
Global Hepatorenal Syndrome market size is expected to reach $1.91 Billion by 2030 at 6.9%, rising prevalence of liver diseases driving the growth of the market due to increasing risk of kidney dysfunction
Read More
Global Hepatitis Diagnostic Tests market size is expected to reach $6.6.72 billion by 2030 at 6.6%, segmented as by blood tests, serological tests, polymerase chain reaction (pcr) tests, enzyme-linked immunosorbent assays (elisa)
Read More
Global Hepatitis D market size is expected to reach $0.93 billion by 2030 at 4.1%, rising hepatitis b prevalence fuels growth in the market
Read More
The hepatitis C testing market will grow from $1.78 in 2024 to $1.32B in 2025 at 6.1% CAGR, driven by rising disease prevalence and expanding health programs.
Read More
Global Hepatitis C Market Set for Strong Expansion, Reaching $153.66 Billion With 15.4% CAGR by 2030
The hepatitis C market is projected to reach $153.67 billion by 2030, growing at 15.4% CAGR, driven by direct-acting antivirals, early screening, and expanded access to treatment.
Read More
Global Hepatic Encephalopathy market size is expected to reach $2.38 billion by 2030 at 6%, segmented as by antibiotics, rifaximin, neomycin, metronidazole
Read More